Catechol protected levodopa diester prodrugs, compositions, and methods of use
作者： Jia-Ning Xiang , Cindy X. Zhou , Fenmei Yao , Mark Q. Nguyen
DOI:
关键词:
摘要: Catechol protected levodopa diester prodrugs pharmaceutical, compositions comprising catechol prodrugs, and methods of using such pharmaceutical for treating diseases as Parkinson's disease are provided.
lens.org参考文章(128)
E. C. Hirsch, G. Höglinger, E. Rousselet, T. Breidert, K. Parain, J. Feger, M. Ruberg, A. Prigent, C. Cohen-Salmon, J.-M. Launay, Animal models of Parkinson’s disease in rodents induced by toxins: an update Advances in Research on Neurodegeneration. pp. 89- 100 ,(2003) , 10.1007/978-3-7091-0643-3_6
Joseph A. Fix, Jose Alexander, Margot Cortese, Karen Engle, Paula Leppert, Arnold J. Repta, Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption. Pharmaceutical Research. ,vol. 6, pp. 501- 505 ,(1989) , 10.1023/A:1015924724973
Jakowec Mw, Petzinger Gm, Tolwani Rj, Green S, Waggie K, Experimental models of Parkinson's disease: insights from many models. Laboratory Animal Science. ,vol. 49, pp. 363- 371 ,(1999)
Jane P. F. Bai, pGlu-L-Dopa-Pro: A Tripeptide Prodrug Targeting the Intestinal Peptide Transporter for Absorption and Tissue Enzymes for Conversion Pharmaceutical Research. ,vol. 12, pp. 1101- 1104 ,(1995) , 10.1023/A:1016239321494
Richard C. Capozza, Polymeric orthoesters housing beneficial drug for controlled release therefrom ,(1976)
Edward Emil Schmitt, Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality ,(1976)
Nicholas S. Bodor, Stefano A. Pogany, Kenneth B. Sloan, Novel dopa/dopamine prodrugs ,(1980)
Alan S. Michaels, Structured bioerodible drug delivery device ,(1974)
Werner Kramer, Gunther Wess, Modified bile acid conjugates, and their use as pharmaceuticals ,(1994)